These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9600631)

  • 1. Responses to neuropeptide Y in adult hamster suprachiasmatic nucleus neurones in vitro.
    Cutler DJ; Piggins HD; Selbie LA; Mason R
    Eur J Pharmacol; 1998 Mar; 345(2):155-62. PubMed ID: 9600631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase shifting of circadian rhythms and depression of neuronal activity in the rat suprachiasmatic nucleus by neuropeptide Y: mediation by different receptor subtypes.
    Gribkoff VK; Pieschl RL; Wisialowski TA; van den Pol AN; Yocca FD
    J Neurosci; 1998 Apr; 18(8):3014-22. PubMed ID: 9526018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y phase shifts circadian rhythms in vivo via a Y2 receptor.
    Huhman KL; Gillespie CF; Marvel CL; Albers HE
    Neuroreport; 1996 May; 7(7):1249-52. PubMed ID: 8817542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological responses of hamster suprachiasmatic neurones to neuropeptide Y in the hypothalamic slice preparation.
    Mason R; Harrington ME; Rusak B
    Neurosci Lett; 1987 Sep; 80(2):173-9. PubMed ID: 3317135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y is a vasoconstrictor and adrenergic modulator in the hamster microcirculation by acting on neuropeptide Y1 and Y2 receptors.
    Boric MP; Martinez A; Donoso MV; Huidobro-Toro JP
    Eur J Pharmacol; 1995 Dec; 294(2-3):391-401. PubMed ID: 8750699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y phase shifts the circadian clock in vitro via a Y2 receptor.
    Golombek DA; Biello SM; Rendon RA; Harrington ME
    Neuroreport; 1996 May; 7(7):1315-9. PubMed ID: 8817557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian phase shifts to neuropeptide Y In vitro: cellular communication and signal transduction.
    Biello SM; Golombek DA; Schak KM; Harrington ME
    J Neurosci; 1997 Nov; 17(21):8468-75. PubMed ID: 9334419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y depresses GABA-mediated calcium transients in developing suprachiasmatic nucleus neurons: a novel form of calcium long-term depression.
    Obrietan K; van den Pol AN
    J Neurosci; 1996 May; 16(10):3521-33. PubMed ID: 8627385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bicuculline blocks neuropeptide Y-induced phase advances when microinjected in the suprachiasmatic nucleus of Syrian hamsters.
    Huhman KL; Babagbemi TO; Albers HE
    Brain Res; 1995 Mar; 675(1-2):333-6. PubMed ID: 7796148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y rapidly reduces Period 1 and Period 2 mRNA levels in the hamster suprachiasmatic nucleus.
    Fukuhara C; Brewer JM; Dirden JC; Bittman EL; Tosini G; Harrington ME
    Neurosci Lett; 2001 Nov; 314(3):119-22. PubMed ID: 11704298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonistic regulation of alpha 2-adrenoceptors by neuropeptide Y receptor subtypes in the nucleus tractus solitarii.
    Yang SN; Fior DR; Hedlund PB; Agnati LF; Fuxe K
    Eur J Pharmacol; 1994 Dec; 271(1):201-12. PubMed ID: 7698202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuropeptide Y Y5 receptor mediates the blockade of "photic-like" NMDA-induced phase shifts in the golden hamster.
    Yannielli PC; Harrington ME
    J Neurosci; 2001 Jul; 21(14):5367-73. PubMed ID: 11438613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel neuropeptide Y analog, N-acetyl [Leu28,Leu31]neuropeptide Y-(24-36), with functional specificity for the presynaptic (Y2) receptor.
    Potter EK; Barden JA; McCloskey MJ; Selbie LA; Tseng A; Herzog H; Shine J
    Eur J Pharmacol; 1994 May; 267(3):253-62. PubMed ID: 8088364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for Y1 and Y2 subtypes of neuropeptide Y receptors linked to opposing postjunctional effects observed in rat cardiac myocytes.
    McDermott BJ; Millar BC; Dolan FM; Bell D; Balasubramaniam A
    Eur J Pharmacol; 1997 Oct; 336(2-3):257-65. PubMed ID: 9384241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y phase advances the in vitro hamster circadian clock during the subjective day with no effect on phase during the subjective night.
    Harrington ME; Schak KM
    Can J Physiol Pharmacol; 2000 Feb; 78(2):87-92. PubMed ID: 10737670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of neurotensin on discharge rates of rat suprachiasmatic nucleus neurons in vitro.
    Coogan AN; Rawlings N; Luckman SM; Piggins HD
    Neuroscience; 2001; 103(3):663-72. PubMed ID: 11274786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y-induced contraction is mediated by neuropeptide Y Y2 and Y4 receptors in the rat colon.
    Pheng LH; Perron A; Quirion R; Cadieux A; Fauchère JL; Dumont Y; Regoli D
    Eur J Pharmacol; 1999 Jun; 374(1):85-91. PubMed ID: 10422644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine.
    Tschöpl M; Miller RC; Pelton J; Stoclet JC; Bucher B
    Br J Pharmacol; 1993 Nov; 110(3):1098-104. PubMed ID: 8298798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of neuropeptide Y and [Leu31,Pro34] neuropeptide Y on experimental gastric lesion formation and gastric secretion in the rat.
    Penner SB; Smyth DD; Glavin GB
    J Pharmacol Exp Ther; 1993 Jul; 266(1):339-43. PubMed ID: 8101219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
    Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L
    Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.